Clinical Trial Update: RGD-K5 in Head and Neck Cancer Patients

View source ↗

Summary

This document reports a clinical trial update for the investigational agent RGD-K5 in patients with head and neck cancer; the current trial status is not provid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• RGD-K5

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Head and Neck Neoplasms | Status: UNKNOWN